Seagen/Genmab's Tivdak Set To Take On Merck’s Keytruda

 
• By Joseph Haas
Businessman Success. A businessman launching upwards, paperwork flying everywhere!
Seagen gets its fourth FDA approval and third ADC with Tivdak okay

More from New Products

More from Scrip